Protein production services compared: what separates providers once the expression system is fixed, and the terms worth negotiating

Reading the quotes

1. Which systems does the provider actually run. Most providers list every expression system and run one or two well. Ask how many projects in your system they completed in the past year and ask to speak to a customer. Capability breadth on a website is not capability.
2. What analytics are inside the price. Purity, concentration, identity, aggregate and endotoxin may each be included or extra, and a cheaper quote frequently excludes the analytics that make the material usable. Normalise every quote against the same analytical package.
3. Timelines, and what they are measured from. A stated turnaround may run from order, from receipt of materials, or from a successful feasibility stage. Establish the start point and what pauses the clock, because this is where expectations diverge most often.
4. What happens when a batch misses specification. Ask directly: who pays, who investigates, and is a repeat included. A provider with a clear written answer has been here before; one that treats the question as hypothetical will negotiate it while you are waiting for protein.
5. Ownership and the repeat order. Constructs, cell banks, process descriptions and any improvement made during the work should have their ownership settled in writing before the first batch. This is the leverage point, and it disappears once the project has started.

Staging, even for production

Even for a known process, a small confirmation run before a large batch is usually worth its cost, because it verifies the process in that provider's hands with your materials. Programmes that skip it occasionally lose a full-scale batch to something a small run would have exposed.

Where the protein is new to the provider, a feasibility stage is not optional. A fixed price for an unfamiliar protein is a risk premium you are paying whether or not the risk materialises.

Shipping, storage and arrival

Specify the format, buffer, concentration and shipping condition, and require a temperature record. Protein that arrives thawed is a batch lost, and the conversation about who bears that is much easier when the shipping specification was written down.

Agree acceptance criteria and an inspection window on arrival, so that a problem is identified while the provider still has the retains to investigate it.

An fc fusion protein, and what fusing to an Fc buys

Fusing a protein to an immunoglobulin Fc domain buys three things: a much longer half life through neonatal Fc receptor recycling, dimerisation because the Fc pairs, and a purification handle since protein A works on the fusion as it does on an antibody. The costs are real too. The dimer changes the biology of anything that signals by clustering, the Fc carries effector function unless it is engineered out, and the linker between the partners sets both the flexibility and the proteolysis. Specify the isotype, the mutations and the linker with the sequence, not after expression.

Protein services, and the six things they cover

Protein services is an umbrella over six purchases: gene to protein expression, custom antibody work, purification of material you supply, characterisation and analysis, assay development, and process development for something heading to manufacture. They are priced and scoped differently and few providers are strong at all of them, so the first question is which of the six a quote is for. The second is the deliverable: milligrams at a stated purity, a report, or a process. A provider who answers both in writing is comparable with another; one who quotes a day rate is not.

peg protein conjugates and what the modification changes

A peg protein conjugate carries polyethylene glycol chains to extend half life and lower immunogenicity, and the consequences for the laboratory are practical: apparent mass rises far above the calculated value, mobility on a gel is anomalous, and many assays read the conjugate differently from the naked protein. Site and degree of modification are the specification rather than the average mass.

synthetic proteins and what the phrase covers

synthetic proteins may mean chemically synthesised peptides joined into a chain, a recombinant protein from a synthetic gene, or a designed sequence with no natural counterpart, and the three are different services. Beyond about fifty residues chemistry gives way to expression, which is the practical boundary a quote turns on.

protein crystallography and what it needs from a prep

protein crystallography needs milligrams of homogeneous, monodisperse protein, so it is a purification problem before it is a diffraction one: a preparation that aggregates or carries multiple conformations will not crystallise however much of it there is. Construct design, including where the flexible regions are trimmed, is usually what makes a target crystallise at all.

gst affinity chromatography and the tag behind it

gst affinity chromatography captures a fusion protein on immobilised glutathione, which gives a clean single step from a crude lysate and leaves a large tag behind that often has to be cleaved. The tag aids solubility, which is why it is chosen for difficult targets, and dimerises, which is why it is removed before anything is measured.

Common questions

How do I compare protein production quotes?

Normalise them against the same specification and the same analytical package, establish what each timeline is measured from, and ask what happens when a batch misses specification. Quotes that look similar frequently include very different things.

Does the provider need experience in my expression system?

Yes, and websites list far more systems than providers run well. Ask how many projects in your system they completed recently and ask to speak to one of those customers.

Should I do a small run first?

Usually. A confirmation run verifies the process in that provider's hands with your materials, and it costs far less than losing a full-scale batch to something it would have exposed.

What should I own at the end?

The construct, the cell bank, the process description and any improvement made along the way, as agreed in writing before the first batch. After work starts, the leverage to settle it is gone.

Browse by service class

• Compare Gene synthesis on advertised prices